Tiga Tx

Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.

02Backed By1 investor

03Similar Companies

RL

Rin Laboratory

Biotech & Life Sciences

→

TT

TT

AT

KB

04Startup DNA

7

signals

Sectors
Business Model
Technology